Pyrrolidine compounds which modulate the CB2 receptor

US8629157B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Angela Berry · Gaylordsville, US
• Rajashekhar Betageri · Bethel, US
• Eugene Richard Hickey · Danbury, US
• Someina Khor · Abingdon, GB
• Doris Riether · Biberach an der Riß, DE
• Lifen Wu · New Milford, US
• Renee M. Zindell · New Milford, US

Key dates

• Filing date: Dec 15, 2009
• Grant date: Jan 14, 2014
• Expiry date: Dec 15, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain (I).